Olmesartan medoxomil, hydrochlorothiazide; 20mg/12.5mg, 40mg/12.5mg, 40mg/25mg; tabs. Olmesartan blocks the vasoconstrictor effects of angiotensin II by selectively blocking the binding of angiotensin ...

Parsippany, NJ (May 27, 2005) – Data from two clinical studies presented at the American Society of Hypertension's Twentieth Annual Scientific Meeting (ASH 2005) in San Francisco demonstrated that ...

Benicar was developed by Scottish pharmaceutical company Daiichi Sankyo and was used by the U. According to the FDA, primarily In some benicar hct 40 25 mg tablets, patients have been assessed for ...

Parsippany, NJ (May 26, 2004) – New data from two different clinical studies demonstrated that patients with hypertension can achieve more aggressive blood pressure goal rates using antihypertensive ...

Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB). Olmesartan Medoxomil and Hydrochlorothiazide combines an ARB with a thiazide diuretic. Olmesartan Medoxomil is indicated for the ...

PARSIPPANY, N.J., June 16 A new study published in thecurrent Journal of the American Society of Hypertension demonstrates that thehypertension treatment olmesartan medoxomil was effective in ...

WASHINGTON, DC — The US Food and Drug Administration (FDA) has approved the first generic versions of four drugs that contain the widely used blood pressure-lowering medication olmesartan ...

The FDA is warning that the widely-used antihypertensive agent olmesartan (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) may cause severe diarrhea. According to an FDA safety ...